Iomab-B’s impact on the treatment of AML

Physicians Panel Discussion on the Future of AML Treatment for Elderly Relapsed/Refractory Patients: New York BIO Conference Panelists Highlight Improved Survival in Elderly Relapsed/Refractory Patients

Sergio Giralt MD, Chief of Adult Bone Marrow Transplant Service; Memorial Sloan Kettering

Joseph Jurcic MD, Director of Hematologic Malignancies; Columbia University Medical Center

Resources

• Slides
• Highlights
• Iomab-B’s impact on the treatment of AML